Navigation Links
Mast Therapeutics Reports Third Quarter 2013 Financial Results
Date:11/4/2013

SAN DIEGO, Nov. 4, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the quarter ended September 30, 2013.

Brian M. Culley, Chief Executive Officer, said: "We continue to focus on EPIC, our pivotal phase 3 study of MST-188 in sickle cell disease.  We almost doubled the number of open clinical sites since the end of the second quarter and are approaching our goal of opening 40 clinical sites in the U.S. Beginning next year, we also plan to open approximately 30 clinical sites outside the U.S."

Mr. Culley continued: "In addition to sickle cell disease, we are evaluating MST-188 in other areas of significant unmet medical need and plan to initiate a 60-patient phase 2 study in acute limb ischemia in early 2014.  This study will determine whether MST-188 improves the effectiveness of existing thrombolytic agents, such as Activase®, a tissue plasminogen activator (tPA) that is approved to treat stroke, heart attack and pulmonary embolism.  If our phase 2 study demonstrates that MST-188 improves the 'clot busting' activity of tPA, we believe it will open the door to developing MST-188 in combination with tPA in all settings in which thrombolytics are used, most notably stroke." 

Third Quarter 2013 Operating ResultsThe Company's net loss for the third quarter of 2013 was $5.3 million, or $0.05 per share (basic and diluted), compared to a net loss of $3.2 million, or $0.07 per share (basic and diluted), for the same period in 2012.

Research and development (R&D) expenses for the third quarter of 2013 were $3.1 million, an increase of $1.4 million, or 87%, compared to $1.7 million for the same period in 2012. The increase was primarily due to increases of $1.3 million in external clinical study fees and expenses and $
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
2. Echo Therapeutics Schedules Third Quarter 2013 Financial Results for Thursday, November 7, 2013
3. G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum
4. Cell Therapeutics Reports Third Quarter 2013 Financial Results
5. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
6. Abide Therapeutics Appoints Dr. Gary ONeill as Vice President of Biology
7. Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013
8. Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure
9. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
10. ISSYS Inc. will showcase its Titan Wireless Implantable Hemodynamic Monitor and its clinical study summary at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference (Booth 1638) in San Francisco (October 29 to 31, 2013)
11. Aratana Therapeutics Adds to Commercial Leadership Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 Richmond Pharmacology is ... with a worldwide reputation for excellence in clinical ... in peer reviewed medical journals. Its officers are ... in discussions about rules for transparency and publication ... http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research is conducted ...
(Date:5/21/2015)... Research and Markets ( ... "North American Active Wound Care Market by ... & Ulcer), by End-User (In-Patient, & Out-Paient) - ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North ... grow at a CAGR of 3.1% from 2014 ...
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth # ... Health Record (EHR) is invaluable in any hospital ... are now a requirement and mainstream in healthcare, ... into the EHR is gaining traction in MEDITECH ... Holmes, RN, Site Project Manager & Clinical Analyst ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3
... Highlights ... generation of medical image management products and services. ... technologists. Harris Corporation (NYSE: ... company, and Johns Hopkins Medicine today announced a joint ...
... American Regent is conducting a voluntary nationwide recall of the following products:Con c entate dSodi ... mL Sing l e Do s e V i al ... c entatedS o di u mCh l or i d eInjection ... c yBulka c ka g e N DC# 0 5 ...
Cached Medicine Technology:Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 2American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 3American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 4American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs 5
(Date:5/25/2015)... New York, New York (PRWEB) May 25, 2015 ... and distributor of patented products, launches The Preventer, a ... property from the dangers of fire. , "House fires ... yearly," says Scott J. Cooper, CEO and Creative Director ... of home fire deaths result from homes that have ...
(Date:5/25/2015)... 24Hr HomeCare is proud to announce that David ... and Ryan Iwamoto, Co-Founder & CMO, are Finalists for ... Awards in Greater Los Angeles. The award is presented ... financial performance, and a personal commitment to their communities. ... ongoing success of our organization,” said Co-Founder & CEO, ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Stanley ... awards for design of the wastewater treatment ... Iowa.    The project received a National Recognition Award from the ... Award from ACEC – Iowa. Competitions held by ... , The $50.2 million expansion is Iowa City’s largest ...
(Date:5/25/2015)... May 25, 2015 Join Fiona's Soccer Camp ... two-hour instructional clinic. Irish National Player, Fiona O'Sullivan will ... them a taste of her coaching style. Fiona has three ... Camps in Novato are at Lynwood Elmentary School (June 15-19) ... High School - June 6th, 2015 - 1:00-3:00pm. Bring a ...
(Date:5/25/2015)... White Plains, NY (PRWEB) May 25, 2015 ... LEED AP, principal of PBDW Architects in New York City, ... which is part of the hospital’s ongoing Legacy Lobby Lecture ... campus in White Plains. White is the great grandson of ... firm responsible for the design of Burke’s campus 100 years ...
Breaking Medicine News(10 mins):Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 3Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3
... have found a breakthrough in the treatment of breast ... of therapies.// ,According to Professor Miles Prince from ... positron emission tomography (PET) would probably change the way ... used (PET) scans to monitor breast cancer patients to ...
... UK, 40% Of Adults Cannot Manage Without Cell Phones.The ... who had conducted the research//, claimed that certain some ... cell phones. In his study on how students felt ... the behaviors displayed, closely resembled symptoms of ‘pathological gambling’. ...
... Richards marks the rapid increase in esophageal cancer cases in the ... cancer.// Only 16 % or around 2,200, of the 14,000-esophageal cancer ... years. ,There has been a 6-fold annual rise in the ... to experts. Rise in obesity cases has been the major cause. ...
... treat migraine headaches can be effective in cluster headaches ... nerves that carry pain signals, Dr. Peter Goadsby, professor ... ,Cluster headaches are not as common as migraines and ... with cluster headaches. In the final analysis 69 patients ...
... on the anvil to raise the legal age for buying cigarettes ... health for NHS Scotland has led a team of experts //who ... Executive. ,Health Minister Andy Kerr said that such a move ... "We must get a strong message across to young Scots about ...
... Association of Tamil Nadu has called for designational equality ... ,According to the association, the move will not ... will it exempt the government doctors from performing their ... association has also requested the Government to look into ...
Cached Medicine News:Health News:Aussie Doctors Claim Breakthrough in Breast Cancer Treatment 2Health News:Rise in Esophageal Cancer is emphasized by Richards’ deat 2
... Medelec Synergy N-EP provides total testing ... smaller instrument is driven by space ... testing equipment on the move ... 2, 5, or 10-channel Medelec Synergy ...
Neuropack MEB-2200 evoked potential/EMG measuring system is user friendly Windows NT, Pentium III PC-based EP/EMG measuring system....
Sierra Wave Quickreport eliminates most dictation. Study driven functions make testing faster and easier. Complete 2/4 channel EMG/NCV/EP....
...
Medicine Products: